Substantial Matters: Life & Science of Parkinson’s artwork

Substantial Matters: Life & Science of Parkinson’s

200 episodes - English - Latest episode: 27 days ago - ★★★★ - 111 ratings

How can people with Parkinson's live a better life today? Join the Parkinson's Foundation as we highlight the treatments and techniques that can help all people affected by Parkinson’s live a better life today, as well as the research that can bring a better tomorrow.

Medicine Health & Fitness parkinsons parkinson
Homepage Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Episodes

The Newly Diagnosed Experience

October 06, 2020 11:00 - 18 minutes - 8.16 MB

When a person shows up in a doctor’s office with symptoms that may be related to Parkinson’s disease (PD), the diagnosis may not be obvious since symptoms often differ from person to person or could be indicative of other conditions. It’s not uncommon for people go from doctor to doctor over months or even years before they get a correct diagnosis. A visit to a movement disorders neurologist may result in a faster PD diagnosis, but unless PD is suspected, that may not be the first medical sp...

Movement Strategies: Mobility, Falls & Freezing of Gait

September 22, 2020 11:00 - 21 minutes - 13.5 MB

Movement issues are central to Parkinson’s disease (PD), even in the early stages before complications may become obvious. From the time of diagnosis and throughout the course of the disease, movement and staying physically active are essential. Both regular exercise and physical therapy can help people with PD keep moving well and for as long as possible. The Parkinson’s Outcomes Project, the largest clinical study of PD, conducted across the Parkinson’s Foundation’s Centers of Excellence n...

Retention Rates in Longer Clinical Studies

September 08, 2020 11:00 - 16 minutes - 10.3 MB

Clinical studies, studies that involve people, first use healthy people to test a drug’s safety and then use people with a disease or condition to prove that the drug works as intended. They are essential for bringing any new therapy to the public. Getting U.S. Food and Drug Administration approval for devices require rigorous studies, as well. Recruiting enough people to participate is often a long process, and for trials that may go on for a year or more, retaining people in the studies is...

The Skinny on Clinical Trials in PD

August 25, 2020 11:00 - 20 minutes - 13.1 MB

When people take a prescribed drug, they rarely if ever consider how it came to be. They assume it is the right drug and will work safely as it is supposed to. But leading up to that drug being available is a long process of discovery or invention of the molecule based on knowledge of the biology it is supposed to affect, then testing in the laboratory and in animals, and several phases of testing in people to make sure that it is safe and effective. Each of these steps takes time and lots o...

What is Lewy Body Dementia and How Does it Relate to Parkinson’s?

August 11, 2020 11:00 - 21 minutes - 14.1 MB

Parkinson’s disease (PD) is a multi-factorial condition, with the potential to affect all aspects of people’s lives. Besides the well-known motor and non-motor symptoms, it also can lead to dementia, characterized by impairment of such mental functions as cognition, memory, and judgment, leading to forgetfulness, limited social skills, and difficulties in daily functioning. The decline in mental abilities can range from mild cognitive impairment that does not affect work or daily functioning...

¡EN ESPAÑOL! El gran impacto de los líderes de la salud en la comunidad del Parkinson

August 04, 2020 11:00 - 14 minutes - 13.2 MB

A través del alcance comunitario para la comunidad del Parkinson de habla hispana, vemos que hay una gran necesidad de servicios no solo en español, sino que respondan a la cultura. También existe un gran interés en desarrollar servicios para la población con acceso limitado a estos recursos. Por esta razón, Claudia Martinez, coordinadora de alcance hispano del Muhammad Ali Parkinson Center, parte del grupo de Centros de Excelencia de la Parkinson’s Foundation, realizó un entrenamiento para ...

Personalized Medicine: The Voice of the Patient

July 28, 2020 11:00 - 15 minutes - 9.47 MB

Personalized medicine has garnered a lot of attention over the past decade. Usually it means determining the factors for each person that affect their health, their diseases, and potentially their treatments. Some examples are biomarkers that are found in their blood, their genetic make-up, diet and nutrition, behaviors, and environment. One example is the Parkinson’s Foundation’s PD GENEration initiative that offers free genetic testing and counseling for people with Parkinson’s disease (PD...

Importance of Early Detection of Swallowing Disturbances

July 14, 2020 11:30 - 12 minutes - 7.33 MB

Since swallowing involves a complex and coordinated sequence of muscular movements, it is not surprising that difficulties swallowing food or liquids are common in a movement disorder such as Parkinson’s disease (PD). They can cause problems from the inconvenient to troubling, dangerous, or life threatening. Drooling is uncomfortable and can result in social isolation. Not taking in enough food to get adequate calories and nutrients may cause hunger, malnutrition, weight loss, and frailty. O...

¿Cuál es el siguiente paso? Cómo participar en las pruebas genéticas

July 07, 2020 11:30 - 14 minutes - 13.5 MB

La participación de hispanos en estudios genéticos es necesaria para mejorar el entendimiento de la enfermedad del Parkinson. También aseguraría que los datos de los hispanos estén representados y que esos resultados se tomen en cuenta para iniciativas de salud en caso exista diferencia entre poblaciones. Sin embargo, vemos un porcentaje muy bajo de representación de esta comunidad, debido a varias razones como la falta de información sobre cómo funcionan los estudios y acceso a los hospital...

Managing Anxiety with PD

June 30, 2020 11:30 - 14 minutes - 9.19 MB

The Parkinson’s Outcomes Project (POP) is the largest-ever clinical study of people with Parkinson’s disease (PD). Since the beginning of this groundbreaking initiative in 2009, Parkinson’s Foundation Centers of Excellence have been tracking and monitoring the care of more than 13,000 people in five countries with all stages of PD. The goal is to find the most effective therapies, study their benefits, and determine the best candidates for each treatment.   One of the findings of POP is ...

Staging PD – UPDRS: What it Measures and What Your Score Means

June 16, 2020 11:00 - 20 minutes - 13 MB

Disease rating scales give clinicians a snapshot in time of the severity of a disease, how it may be affecting a patient, and areas where therapies may be applied. Put together over time, rating scale results can indicate the progression of a disease and possibly help with long term planning. In the case of Parkinson’s disease (PD), the Hoehn and Yahr scale, published in 1967, describes the progression of PD according to five stages from earliest to most advanced, based on severity of sympto...

Neuropsychological Evaluations for PD

June 02, 2020 11:00 - 19 minutes - 13.3 MB

Parkinson’s disease (PD) is much more than a movement disorder. It can have wide ranging effects throughout the body. In terms of the brain, people with PD may experience changes in cognition, mood, emotion, perception, attention, sleep, memory, motivation, and the senses, as well as drug-induced behavioral changes. One of the key professionals on a comprehensive PD treatment team is the neuropsychologist, a person with training and expertise in asking questions and administering screening a...

¡EN ESPAÑOL! La representación hispana en la comunidad del Parkinson

May 26, 2020 11:00 - 12 minutes - 11.1 MB

La participación de hispanos en estudios genéticos es necesaria para mejorar el entendimiento de la enfermedad del Parkinson. También aseguraría que los datos de los hispanos estén representados y que esos resultados se tomen en cuenta para iniciativas de salud en caso exista diferencia entre poblaciones. Sin embargo, vemos un porcentaje muy bajo de representación de esta comunidad, debido a varias razones como la falta de información sobre cómo funcionan los estudios y acceso a los hospital...

Practicing Mindfulness Techniques Part 2

May 19, 2020 11:00 - 17 minutes - 23.7 MB

Mindfulness is a therapeutic approach to help with stress reduction and its practice can promote good physical and mental health. It is based on deliberately focusing one’s awareness on the present moment with calmness in a non-judgmental way. In those moments, experiences may be external or internal. Examples of external experiences are what the body senses in the surroundings, such as feeling a breeze, hearing a distant train whistle, or smelling a cooking aroma. Internal experiences may b...

How Mindfulness Techniques Impact the Nervous System

May 05, 2020 11:00 - 15 minutes - 20.9 MB

Mindfulness is a mental state in which one focuses his or her awareness on the present moment, whether that focus is on the mind, body, or surroundings. In this therapeutic technique, one works towards calmly accepting feelings, thoughts, and bodily sensations in a non-judgmental way with the goal of achieving a state of alertness through a focused relaxation.   The practice of mindfulness can be learned in a relatively short time through in-person sessions or even online. It can lead to...

¡EN ESPAÑOL! ¿Porque son importantes las pruebas genéticas?

April 28, 2020 11:00 - 16 minutes - 15.1 MB

Para entender el rol que juega la genética en la enfermedad de Parkinson, primero hay que entender de que consiste la genética y como la comunidad hispana puede participar en el avance de la investigación a través de las pruebas genéticas.    En este episodio, hablamos con el doctor Ignacio Mata, doctor en neurogenética e investigador principal en el departamento de genómica medica en la Cleveland Clinic sobre la significancia de las pruebas genéticas y de las iniciativas PDGENEration y ...

How Clinical Studies Help People with PD

April 21, 2020 11:00 - 18 minutes - 24.6 MB

Clinical studies fall into two main categories – observational and interventional. An observational study is non-experimental. Researchers observe the effects of a risk factor, such as an inherited gene, or air quality, or a treatment that has already been applied. Researchers have no control over the variables. Such a study can show a correlation between the variable and the observed outcome but cannot prove that one caused the other. In an interventional study, such as a clinical trial, re...

Benefits of Self Awareness with PD

April 07, 2020 11:00 - 14 minutes - 20.8 MB

Self-awareness is an ability to focus on one’s own thoughts, actions, and emotions and evaluate and manage them according to what standards and values you set for yourself. Being self-aware from moment to moment can lead to better self-understanding and an ability to manage thoughts, emotions, strengths, weaknesses, beliefs, and motivations, with a goal of a more peaceful existence. Fortunately, self-awareness can be learned and cultivated using some simple techniques. Dr. Carsten Eggers, Pr...

¡EN ESPAÑOL! Cubriendo la genética con el Dr. Mata: Su trabajo en la genética y su colaboración con la Parkinson’s Foundation

March 31, 2020 11:00 - 8 minutes - 15.9 MB

Para entender el rol que juega la genética en la enfermedad de Parkinson, primero hay que entender de que consiste la genética y como la comunidad hispana puede participar en el avance de la investigación a través de las pruebas genéticas.    En este episodio, hablamos con el doctor Ignacio Mata, doctor en neurogenética e investigador principal en el departamento de genómica medica en la Cleveland Clinic. Este episodio es el primero en una serie de cuatro episodios con el doctor Mata, en...

An Aware in Care Success Story

March 24, 2020 11:00 - 18 minutes - 25.1 MB

The Aware in Care (AIC) kit is one way to ensure patient safety during a hospitalization. It provides useful tools to use before, during, and after a hospitalization, such as a list of medications that a person with Parkinson’s disease is taking, instructions to the hospital staff about dispensing medications on the person’s individual schedule, a list of drugs that should not be administered, and more. As useful as the AIC kits may be for the person with PD, another aspect for a safe and su...

El Diagnóstico Inicial y la Vergüenza Asociada con la Enfermedad de Parkinson

March 17, 2020 11:00 - 24 minutes - 22.4 MB

A veces es difícil diagnosticar la enfermedad de Parkinson (EP) en un inicio ya que la forma de que se presenta siempre varía. Por ejemplo, para ciertas personas, la enfermedad se puede presentar con mucho temblor, mientras que otros pueden sentir un trastorno de balance o rigidez. Por estas diferencias en cada persona con EP, es difícil hacer un diagnóstico certero inicialmente. En la primera parte de este episodio, el doctor Guillermo Moguel-Cobos, neurólogo en el centro de atención Muhamm...

Practicing Hospital Safety

March 10, 2020 11:00 - 24 minutes - 32.5 MB

When people with Parkinson’s disease (PD) are admitted to a hospital, it is most often not for their PD but is for some other condition. Nonetheless, they have unique needs related to their PD that nurses and doctors may not be aware of. Thus, the patient or caregiver must inform the staff of those needs. A major consideration is the timing of medications. The typical hospital practice of dispensing medications every three or four hours may not work for someone with PD who has carefully work...

Pharmacy Challenges with PD

February 25, 2020 12:00 - 21 minutes - 29.1 MB

Medication is a mainstay of treatment of Parkinson’s disease (PD), and can vary for each person with PD. Each medication has its own properties, and healthcare professionals have reasons to choose certain ones at various times as conditions warrant. At those times, people with PD and their care partners need to ask questions about the reasons for starting specific medications, what they can expect, and whether they will interact well with other medications. This advice applies to all medicat...

A Multidisciplinary Approach to PD

February 11, 2020 12:00 - 15 minutes - 22.4 MB

As for many chronic conditions, a multidisciplinary, team approach can often produce the best outcomes for people with Parkinson’s disease (PD). With many health care professionals specifically qualified in PD working together in a coordinated manner, treatment can focus on current areas of concern and those that come up as the disease progresses. But questions arise as to how often the person with PD and care givers should visit their health care professionals, how to provide care with the ...

¡EN ESPAÑOL! El Parkinson es mucho más que un temblor: ansiedad, depresión y apatía

February 04, 2020 12:00 - 19 minutes - 17.8 MB

Hay muchos síntomas que no son motores que se presentan en la enfermedad de Parkinson. Estos síntomas pueden incluir depresión, ansiedad, trastornos del sueño y signos cognitivos.   En este episodio, hablamos con la doctora Irene Litvan, Profesora de Neurociencias y Directora del Centro de Parkinson y Otros Trastornos del Movimiento (PMDC) de la Universidad de California San Diego (UCSD), sobre la causa de los síntomas no-motores de la enfermedad de Parkinson, como pueden detectar estos ...

Genetics and PD: What do we know so far?

January 28, 2020 12:00 - 16 minutes - 22.1 MB

New tools in genetics are providing researchers with insights into diseases never before obtainable. For Parkinson’s disease (PD), research promises to reveal specific genes and mutations that contribute to the risk of developing PD as well as mechanisms by which these genes act. Along these lines, the Parkinson’s Foundation has launched PD GENEration, a flagship initiative that offers free genetic testing and genetic counseling for people with PD. Participating and contributing one’s geneti...

What is Deep Brain Stimulation?

January 14, 2020 12:00 - 27 minutes - 40 MB

Among the treatments for Parkinson’s disease (PD), the most common are medications, which can work well up to a point. But when motor symptoms are not adequately controlled with drugs, deep brain stimulation (DBS) may be an option. Using electrodes placed in the brain, an implantable pulse generator (IPG) placed in the chest or abdomen, and a wire that connects the two, this system targets electrical currents to precise structures within the brain to block the abnormal nerve signals that cau...

A Western Perspective on PD: Understanding Complementary Medicine

December 31, 2019 12:00 - 17 minutes - 24.8 MB

When we think of medicine from a Western perspective, we often think of treatments including things such as drugs, surgical operations, or rehabilitation therapies like physical, occupational, or speech therapy. While these treatments may be coordinated by a neurology or movement disorders office, most often they are not.   However, in many Eastern cultures, medicine exists as integrated systems. For example, there is traditional Chinese medicine that considers a vital energy (“ch’i”) ci...

¡EN ESPAÑOL! Entendiendo el horario del medicamento y como prepararse para la cita con el neurólogo

December 24, 2019 12:00 - 11 minutes - 10.1 MB

Para una persona con Parkinson, es muy importante entender los periodos de “on”, cuando tiene efecto el medicamento y “off”, cuando para de tener efecto, para medir cuando tomar las pastillas a tiempo. También es esencial prepararse para la cita con el neurólogo para asegurar que sus preguntas sean contestadas.     En este episodio, hablamos con la doctora Maria Cristina Ospina, neuróloga especialista en Parkinson. Hablamos del significado del horario fijo para el medicamento y también s...

The Role of the Microbiome in PD: Part Two

December 17, 2019 12:00 - 14 minutes - 18.8 MB

Our bodies contain more than just our own human cells. We normally live in harmony with a vast array of microorganisms occupying specific spaces, or niches, on and within us. These bacteria, fungi, viruses, and protozoa form the human microbiome. The ones in the gut, mainly within the colon (large intestine), normally maintain a health balance and keep “bad” microbes from overpopulating that area of the digestive system. The normal gut organisms, consisting of around 1,000 different species ...

Parkinson’s Foundation Center of Excellence: What Does it Take and What Does it Mean?

December 03, 2019 12:00 - 20 minutes - 27.7 MB

Since the early 2000’s, centers of excellence for various diseases or procedures have become common. These are specialized programs within healthcare institutions that bring together experts and resources to target different aspects of the disease or condition to give patients a unified resource for addressing their needs in a comprehensive manner. Besides optimizing resources for patients, the centers of excellence provide advantages for healthcare providers by integrating experts and resou...

The Role of the Microbiome in PD

November 19, 2019 12:00 - 17 minutes - 24.8 MB

How and why Parkinson’s disease (PD) starts and progresses is still not exactly known, but active research points to genetics and environment, among other factors. The environment is both external and internal – external in terms of what people encounter outside their bodies and internal in terms of what is inside their bodies. Researchers studying a variety of diseases have learned the importance of the microbiome in health and disease. The microbiome consists of all those bacteria, fungi, ...

The Role of the Microbiome in PD: Part One

November 19, 2019 12:00 - 17 minutes - 24.8 MB

How and why Parkinson’s disease (PD) starts and progresses is still not exactly known, but active research points to genetics and environment, among other factors. The environment is both external and internal – external in terms of what people encounter outside their bodies and internal in terms of what is inside their bodies. Researchers studying a variety of diseases have learned the importance of the microbiome in health and disease. The microbiome consists of all those bacteria, fungi, ...

PDGENE: Genetic Counseling

November 05, 2019 12:00 - 16 minutes - 22.6 MB

Many diseases have a genetic component. In most instances, these gene variants are risk factors for the disease, that is, they raise the risk that someone might develop the disease. It is estimated that 10% to 15% of people with Parkinson’s disease (PD) have a genetic form of the disease, and several genes have been identified that may raise the risk of developing PD or may affect its severity and course. Professional genetic counselors can help people sort out their risks, advise them on th...

Freezing of Gait

October 22, 2019 11:00 - 14 minutes - 20.1 MB

Problems with gait, or how you walk, are common in Parkinson’s disease (PD). These problems can include slow walking, shuffling, foot drags, less arm swinging than normal, and difficulty turning. One particularly troubling problem is freezing of gait, where a person with PD may be “stuck in their tracks” and feel that his or her feet are glued to the floor. The danger is that the person may fall forward or backward and incur injuries to the head, face, or wrists. Fortunately, there are effec...

Recognizing Non-motor Symptoms in PD

October 08, 2019 11:00 - 15 minutes - 21.4 MB

Parkinson’s disease (PD) is often thought of in terms of its motor symptoms, such as slowness of movement, stiffness, and tremor. While l-dopa and dopaminergic drugs can help alleviate the motor symptoms of PD, patients are often also troubled by common non-motor symptoms such as fatigue, pain, sleep disturbances, constipation, urinary and sexual problems, and disturbed mood or cognition. The good news is there are ways to address these problems, such as with other medications, visits to PD ...

The Background of the PDGENEration Initiative

September 24, 2019 11:00 - 16 minutes - 21.9 MB

People who treat Parkinson’s disease (PD) and many people with PD know that there is not one typical form of the disease. One thing that may affect its symptoms and course is a person’s genetic make-up. The different genes that are risk factors for PD and the variations between them and even within the same gene may determine how the disease presents, progresses, and responds to treatments. With the aim of uncovering genes and mechanisms responsible for PD, the Parkinson’s Foundation initiat...

Navigating Sexuality and Intimacy with PD

September 10, 2019 11:00 - 19 minutes - 26 MB

Sexuality and intimacy can greatly add to quality of life at all adult ages. Sexuality is much more than just physical sexual functioning. It encompasses self-image, attraction to others, and a broad spectrum of emotional components. Certain complex problems may arise for people with Parkinson’s disease (PD), including motor and non-motor symptoms, sexual functioning, diminished pleasure, and changes in relationship dynamics because of PD symptoms or drugs used to treat it. Problems such as ...

Driving with PD: Limitations, Risks & Adjustments

August 27, 2019 11:00 - 20 minutes - 27.2 MB

Driving is a complex skill and behavior but something that we often take for granted since it is a common and crucial part of modern life. It involves attention, vision, perception, cognition, memory, anticipation, motor control, reaction time, and more. Parkinson’s disease (PD) can affect several of these abilities, and as the disease progresses, driving may become more of a problem. So it is crucial that people with PD establish a good rapport with their health care providers to make sure ...

The Launch of the PD GENEration Genetics Initiative

August 13, 2019 11:00 - 18 minutes - 25.5 MB

Parkinson’s disease (PD) may turn out to be not one disease but a group of similar conditions with different genetic risk factors, varying symptoms, and courses. Different genes may have variations between them or even variations within the same gene, with implications for symptoms, progression, and treatments. To help uncover key mechanisms responsible for PD and its progression, the Parkinson’s Foundation has launched PD GENEration: Mapping the Future of Parkinson’s Disease to study the ge...

What is a Disease Modifying Therapy in PD?

July 30, 2019 11:00 - 20 minutes - 30.4 MB

Researchers and clinicians are learning that Parkinson’s disease (PD) is an umbrella term that covers similar but distinct variants of the disease that may result from differences in biology. Symptoms may be similar, but each person’s disease may have different features, rate of progression, needs, and treatments connected to the specific underlying cause. In this era of “personalized” medicine, a goal is to treat each person’s condition according to their unique disease. To do so, neurologi...

Understanding Biomarkers to Deliver Precise Treatments

July 16, 2019 17:27 - 22 minutes - 31 MB

While Parkinson’s disease (PD) is a broad category that includes similar symptoms, each person’s disease may have different features, rate of progression, needs and treatments connected to the specific underlying cause of that person’s disease. As we move towards “personalized” or “precision medicine,” which strives to treat each person’s condition according to their unique disease, research in neurology needs the tools to be able to define differences that can allow a truly personalized app...

Talking to Your Employer About PD Series Part 2: Disability Inclusion and Accommodation at Work

July 02, 2019 11:00 - 18 minutes - 26.2 MB

Many people with Parkinson’s disease want to continue to work and contribute their skills in the workplace. Sometimes all it takes is recognition of their condition by their employer and accommodations to compensate for disabilities. In fact, the Americans with Disabilities Act (ADA) provides certain protections in the workplace for people with disabilities once they reveal their situation to their employers, who are then required to make reasonable accommodations to do the job. In this seco...

Talking to Your Employer About PD Series Part 1: Where to Begin?

June 18, 2019 11:00 - 18 minutes - 26 MB

Employment situations can present a tricky situation for someone with a medical condition such as Parkinson’s disease. One big decision for employees with physical, emotional, or mental conditions is whether and when to disclose to employers or coworkers their condition and what accommodations they may need to do their job. The Americans with Disabilities Act (ADA) provides certain protections against discrimination for employees who disclose their conditions to their employers, who are then...

Alleviating Voice Challenges with PD

June 04, 2019 11:00 - 14 minutes - 19.3 MB

Just as Parkinson’s disease (PD) affects movements in other parts of the body, it can affect muscles of the face, mouth, and throat, leading to problems with speech and swallowing. People with PD may experience voice problems during the course of their disease. The problems tend to increase as the disease progresses but may occur at any stage. Speech is one way we communicate and stay socially engaged, but facial expressions and gestures also convey meaning and intent. Thus, PD can hamper co...

Changing the Hospital Experience through Aware in Care

May 21, 2019 11:00 - 16 minutes - 22.1 MB

People with Parkinson’s disease (PD) need their medications on time, every time. Getting them too soon or too late can cause problems. So when a person with PD enters the hospital, which happens 50 percent more often than their peers, the staff often needs to be educated on the importance of delivering medications at the right dose and at the right times - times that may differ from the usual times that medications are dispensed. When medication timing is off or doses are missed, there can b...

Understanding Brain Imaging in Parkinson’s Disease

May 07, 2019 11:00 - 19 minutes - 28.3 MB

Standard practice in neurology uses imaging, such as magnetic resonance imaging, or MRI, of brain structures to make a diagnosis. But in Parkinson’s disease (PD), additional imaging technologies are needed since MRI is not particularly helpful to make the diagnosis. Recent studies have turned to brain imaging using new technological tools, looking for ways to better assess the disease, predict its progression, and evaluate potential drugs to treat it or slow its progression. Biomarkers  that...

A Look Behind the 2019 World Parkinson Congress

April 23, 2019 11:00 - 15 minutes - 20.9 MB

More than ten million people around the world live with Parkinson’s disease (PD). The World Parkinson Coalition (WPC) is a nonprofit organization that provides an international forum on the disease and every three years holds the World Parkinson Congress. The 2019 congress will be in Kyoto, Japan in early June, bringing together people with PD, care givers, physicians, scientists, nurses, and rehabilitation therapists for a worldwide dialogue to improve and expedite advances in treatment pra...

PD Education Through Community Outreach

April 09, 2019 11:00 - 13 minutes - 18.4 MB

Parkinson’s disease affects people around the world, so societies in different countries manage it according to their own circumstances. Singapore, a modern, prosperous southeast Asian country, has a rapidly aging population, and thus, an increasing need to provide services to people with Parkinson’s, which occurs mainly in older individuals. Workers at the National Neuroscience Institute in Singapore, a Parkinson’s Foundation Center of Excellence, recognized that hospitals and nursing homes...

Expanding PD Medical Education

March 26, 2019 11:00 - 17 minutes - 24 MB

How medical education is structured affects doctors in training, and thus, how they practice later on. Their level of experience with different diseases and conditions determines how they will be able to diagnose and treat the people who come to them for help. Given the relatively limited time for medical school and advanced training in light of the vast variety of diseases, medical educators have to be selective about what they require trainees to experience. A core curriculum gives medic...